News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
604,445 Results
Type
Article (47005)
Company Profile (208)
Press Release (557232)
Multimedia
Podcasts (61)
Webinars (13)
Section
Business (166188)
Career Advice (2532)
Deals (30254)
Drug Delivery (105)
Drug Development (78223)
Employer Resources (148)
FDA (14454)
Job Trends (13156)
News (294261)
Policy (28641)
Tag
Academia (2702)
Academic (1)
Accelerated approval (9)
Adcomms (28)
Allergies (97)
Alliances (43527)
ALS (117)
Alzheimer's disease (1523)
Antibody-drug conjugate (ADC) (178)
Approvals (14429)
Artificial intelligence (309)
Autoimmune disease (33)
Automation (17)
Bankruptcy (324)
Best Places to Work (10742)
BIOSECURE Act (18)
Biosimilars (111)
Biotechnology (167)
Bladder cancer (96)
Brain cancer (37)
Breast cancer (376)
Cancer (2947)
Cardiovascular disease (231)
Career advice (2121)
Career pathing (32)
CAR-T (195)
CDC (32)
Cell therapy (514)
Cervical cancer (21)
Clinical research (64203)
Collaboration (1017)
Company closure (3)
Compensation (508)
Complete response letters (28)
COVID-19 (2647)
CRISPR (63)
C-suite (338)
Cystic fibrosis (112)
Data (3001)
Decentralized trials (2)
Denatured (11)
Depression (73)
Diabetes (344)
Diagnostics (6150)
Digital health (18)
Diversity (5)
Diversity, equity & inclusion (41)
Drug discovery (147)
Drug pricing (125)
Drug shortages (25)
Duchenne muscular dystrophy (129)
Earnings (60922)
Editorial (44)
Employer branding (20)
Employer resources (136)
Events (88554)
Executive appointments (872)
FDA (16041)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (898)
Gene editing (141)
Generative AI (25)
Gene therapy (398)
GLP-1 (814)
Government (4387)
Grass and pollen (5)
Guidances (179)
Healthcare (17366)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (172)
Immuno-oncology (9)
Indications (38)
Infectious disease (2825)
Inflammatory bowel disease (160)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (121)
Interviews (526)
IPO (14076)
IRA (51)
Job creations (2829)
Job search strategy (1735)
Kidney cancer (15)
Labor market (32)
Layoffs (483)
Leadership (25)
Legal (6074)
Liver cancer (82)
Lung cancer (419)
Lymphoma (208)
Machine learning (11)
Management (53)
Manufacturing (349)
MASH (98)
Medical device (11131)
Medtech (11135)
Mergers & acquisitions (16837)
Metabolic disorders (860)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (134)
Neuropsychiatric disorders (39)
Neuroscience (2247)
NextGen: Class of 2025 (5968)
Non-profit (4207)
Now hiring (41)
Obesity (421)
Opinion (247)
Ovarian cancer (102)
Pain (113)
Pancreatic cancer (120)
Parkinson's disease (191)
Partnered (21)
Patents (297)
Patient recruitment (159)
Peanut (47)
People (54011)
Pharmaceutical (40)
Pharmacy benefit managers (16)
Phase I (20241)
Phase II (28231)
Phase III (21160)
Pipeline (1622)
Policy (201)
Postmarket research (2407)
Preclinical (8531)
Press Release (59)
Prostate cancer (144)
Psychedelics (44)
Radiopharmaceuticals (265)
Rare diseases (497)
Real estate (4561)
Recruiting (59)
Regulatory (20672)
Reports (29)
Research institute (2354)
Resumes & cover letters (392)
Rett syndrome (10)
RNA editing (10)
RSV (50)
Schizophrenia (93)
Series A (154)
Series B (108)
Service/supplier (5)
Sickle cell disease (65)
Special edition (15)
Spinal muscular atrophy (161)
Sponsored (32)
Startups (3202)
State (2)
Stomach cancer (16)
Supply chain (63)
Tariffs (49)
The Weekly (49)
Vaccines (805)
Venture capital (48)
Weight loss (268)
Women's health (35)
Worklife (17)
Date
Today (42)
Last 7 days (367)
Last 30 days (1752)
Last 365 days (29758)
2025 (15964)
2024 (33420)
2023 (37548)
2022 (48355)
2021 (51962)
2020 (49766)
2019 (42559)
2018 (32213)
2017 (29389)
2016 (28178)
2015 (32753)
2014 (25037)
2013 (20812)
2012 (22143)
2011 (22838)
2010 (20403)
Location
Africa (786)
Alabama (59)
Alaska (5)
Arizona (172)
Arkansas (12)
Asia (36726)
Australia (7383)
California (6921)
Canada (2214)
China (678)
Colorado (296)
Connecticut (287)
Delaware (186)
Europe (83745)
Florida (1044)
Georgia (221)
Hawaii (1)
Idaho (52)
Illinois (575)
India (27)
Indiana (335)
Iowa (13)
Japan (224)
Kansas (105)
Kentucky (25)
Louisiana (14)
Maine (53)
Maryland (942)
Massachusetts (5084)
Michigan (224)
Minnesota (373)
Mississippi (2)
Missouri (85)
Montana (22)
Nebraska (22)
Nevada (74)
New Hampshire (67)
New Jersey (1932)
New Mexico (25)
New York (1929)
North Carolina (992)
North Dakota (6)
Northern California (3052)
Ohio (205)
Oklahoma (8)
Oregon (33)
Pennsylvania (1458)
Puerto Rico (17)
Rhode Island (32)
South America (1060)
South Carolina (30)
South Dakota (1)
Southern California (2608)
Tennessee (104)
Texas (1044)
United States (25358)
Utah (212)
Virginia (181)
Washington D.C. (65)
Washington State (593)
West Virginia (4)
Wisconsin (60)
604,445 Results for "ampliphi biosciences formerly known as targeted genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases
June 18, 2025
·
4 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones
June 10, 2025
·
5 min read
Press Releases
Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
June 4, 2025
·
4 min read
Press Releases
Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2
May 29, 2025
·
4 min read
Press Releases
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing
May 15, 2025
·
3 min read
Press Releases
Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics
May 27, 2025
·
7 min read
Press Releases
Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder
June 9, 2025
·
8 min read
Press Releases
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
July 8, 2025
·
6 min read
Press Releases
Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology
May 13, 2025
·
2 min read
1 of 60,445
Next
